Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX
Offer radioactive iodine as first-line definitive treatment for adults with Graves' disease, unless antithyroid drugs are likely to achieve remission or are unsuitable NICE NG145.
Offer a choice of antithyroid drugs (a 12- to 18-month course) or radioactive iodine as first-line definitive treatment if antithyroid drugs are likely to achieve remission NICE NG145.
Offer antithyroid drugs (a 12- to 18-month course) as first-line definitive treatment for adults with Graves' disease if radioactive iodine and surgery are unsuitable NICE NG145.